Risk Factors for and Clinical Outcomes of Polymicrobial Bloodstream Infections

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2022 Mar 10

PMID 35265714

Authors

Zhenhua Qian

Shufang Zhang

Na Li

Weixing Ma

Kai Zhang

Feizhen Song

Cheng Zheng

Li Zhong

Yesong Wang

Jiachang Cai

Hongwei Zhou

Wei Cui

Gensheng Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Although the clinical features of bloodstream infection are well described, the specific clinical characteristics of polymicrobial bloodstream infection have been rarely reported. The objective of this study was to examine the risk factors for and clinical outcomes of polymicrobial bloodstream infection.

Methods: A retrospective observational study was performed from January 2013 to December 2018 in a tertiary hospital. All patients with bloodstream infection were enrolled, and the data were collected from the electronic medical records.

Results: A total of 594 patients were included, 21% (126/594) of whom had polymicrobial infection. The most common copathogen was (20.81%), followed by (16.78%) and (12.08%). Compared with monomicrobial bloodstream infection, polymicrobial bloodstream infection mostly originated from the skin and soft tissue (28.6% vs. 10.5%, < 0.001). Multivariate analysis revealed that burn injury was independently associated with polymicrobial bloodstream infection (adjusted odds ratio, 3.569; 95% confidence interval, 1.954-6.516). Patients with polymicrobial bloodstream infection were more likely to have a longer hospital length of stay [40 (21, 68) vs. 27 (16, 45), < 0.001] and more hospitalization days after bloodstream infection than those with monomicrobial bloodstream infection [22 (8, 50) vs. 13 (4, 28), < 0.001]. However, no significant difference in mortality was observed between the two groups.

Conclusions: Approximately one-fifth of bloodstream infections were polymicrobial in this cohort. The main sources were skin and soft tissue infections, and burn injury was the only independent risk factor. Although mortality did not differ between the groups, considering the limitations of the study, further studies are required to assess the impact of polymicrobial (vs. monomicrobial) bloodstream infection on outcomes.

Citing Articles

Prognostic Factors That Affect Mortality Patients with Bloodstream Infection.

Huang C, Gao Y, Lin H, Fan Q, Chen L, Feng Y Infect Drug Resist. 2024; 17:3825-3837.

PMID: 39247754 PMC: 11380481. DOI: 10.2147/IDR.S475073.

Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon.

Itani R, Khojah H, Karout S, Rahme D, Hammoud L, Awad R Antimicrob Resist Infect Control. 2023; 12(1):136.

PMID: 38031181 PMC: 10685635. DOI: 10.1186/s13756-023-01343-8.

Antimicrobial Resistance and Biofilms Underlying Catheter-Related Bloodstream Coinfection by Complex and .

Stefanek M, Wenner S, Borges V, Pinto M, Gomes J, Rodrigues J Antibiotics (Basel). 2022; 11(9).

PMID: 36140024 PMC: 9495738. DOI: 10.3390/antibiotics11091245.

Molecular Methodologies for Improved Polymicrobial Sepsis Diagnosis.

Doualeh M, Payne M, Litton E, Raby E, Currie A Int J Mol Sci. 2022; 23(9).

PMID: 35562877 PMC: 9104822. DOI: 10.3390/ijms23094484.

Risk Factors for and Clinical Outcomes of Polymicrobial Bloodstream Infections.

Qian Z, Zhang S, Li N, Ma W, Zhang K, Song F Biomed Res Int. 2022; 2022:5122085.

PMID: 35265714 PMC: 8898812. DOI: 10.1155/2022/5122085.

References

Wang X, Zhao C, Li H, Chen H, Jin L, Wang Z . [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016]. Sheng Wu Gong Cheng Xue Bao. 2018; 34(8):1205-1217. DOI: 10.13345/j.cjb.180192. View

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

Liu Q, Wu J, Wang Z, Wu X, Wang G, Ren J . Polymicrobial Bacteremia Involving in Patients with Complicated Intra-Abdominal Infections: Frequency, Co-Pathogens, Risk Factors, and Clinical Outcomes. Surg Infect (Larchmt). 2019; 20(4):317-325. DOI: 10.1089/sur.2018.207. View

Fengcai S, Di X, Qianpeng H, Hongke Z, Yiyu D . [Microbial characteristics in culture-positive sepsis and risk factors of polymicrobial infection in ICU]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016; 27(9):718-23. View

Song F, Zhang K, Huang J, Qian Z, Zhou H, Cai J . Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Bloodstream Infections. Biomed Res Int. 2021; 2021:6619911. PMC: 8235985. DOI: 10.1155/2021/6619911. View

Zhong L, Zhang S, Tang K, Zhou F, Zheng C, Zhang K . Clinical characteristics, risk factors and outcomes of mixed Candida albicans/bacterial bloodstream infections. BMC Infect Dis. 2020; 20(1):810. PMC: 7648279. DOI: 10.1186/s12879-020-05536-z. View

Karakonstantis S, Kritsotakis E, Gikas A . Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options. J Antimicrob Chemother. 2019; 75(2):271-282. DOI: 10.1093/jac/dkz401. View

Zheng C, Cai J, Liu H, Zhang S, Zhong L, Xuan N . Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections. Infect Drug Resist. 2019; 12:3397-3407. PMC: 6827512. DOI: 10.2147/IDR.S217905. View

Metan G, Sariguzel F, Sumerkan B . Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur J Intern Med. 2009; 20(5):540-4. DOI: 10.1016/j.ejim.2009.05.005. View

10.

Tang C, Li J, Shou B, Pan B, Chen T, Xiao Y . Epidemiology and outcomes of bloodstream infections in 177 severe burn patients from an industrial disaster: a multicentre retrospective study. Clin Microbiol Infect. 2017; 24(2):199.e1-199.e7. DOI: 10.1016/j.cmi.2017.06.009. View

11.

Church D, Elsayed S, Reid O, Winston B, Lindsay R . Burn wound infections. Clin Microbiol Rev. 2006; 19(2):403-34. PMC: 1471990. DOI: 10.1128/CMR.19.2.403-434.2006. View

12.

Aliaga L, Mediavilla J, Llosa J, Miranda C, Rosa-Fraile M . Clinical significance of polymicrobial versus monomicrobial bacteremia involving Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 2001; 19(11):871-4. DOI: 10.1007/s100960000392. View

13.

Goto M, Al-Hasan M . Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013; 19(6):501-9. DOI: 10.1111/1469-0691.12195. View

14.

Qian Z, Zhang S, Li N, Ma W, Zhang K, Song F . Risk Factors for and Clinical Outcomes of Polymicrobial Bloodstream Infections. Biomed Res Int. 2022; 2022:5122085. PMC: 8898812. DOI: 10.1155/2022/5122085. View

15.

Idelevich E, Seifert H, Sundqvist M, Scudeller L, Amit S, Balode A . Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey. Clin Microbiol Infect. 2019; 25(11):1399-1407. DOI: 10.1016/j.cmi.2019.03.024. View

16.

Garcia-Garmendia J, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez F, Barrero-Almodovar A, Gili-Miner M . Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis. 2001; 33(7):939-46. DOI: 10.1086/322584. View

17.

Pavlaki M, Poulakou G, Drimousis P, Adamis G, Apostolidou E, Gatselis N . Polymicrobial bloodstream infections: Epidemiology and impact on mortality. J Glob Antimicrob Resist. 2016; 1(4):207-212. DOI: 10.1016/j.jgar.2013.06.005. View

18.

Gales A, Castanheira M, Jones R, Sader H . Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis. 2012; 73(4):354-60. DOI: 10.1016/j.diagmicrobio.2012.04.007. View

19.

Tabah A, Buetti N, Barbier F, Timsit J . Current opinion in management of septic shock due to Gram-negative bacteria. Curr Opin Infect Dis. 2021; 34(6):718-727. DOI: 10.1097/QCO.0000000000000767. View

20.

Humphries R, Ambler J, Mitchell S, Castanheira M, Dingle T, Hindler J . CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests. J Clin Microbiol. 2018; 56(4). PMC: 5869819. DOI: 10.1128/JCM.01934-17. View